Dual-Modality Immunotherapy for HPV Clearance (DUAL-HPV)

NCT07735039 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

76

Enrollment

OTHER_GOV

Sponsor class

Conditions

Human Papillomavirus Infection
Cervical Intraepithelial Neoplasia (CIN)
Low-Grade Squamous Intraepithelial Lesions

Interventions

DRUG: Oral Immunomodulator
DRUG: Vaginal Ovule
OTHER: Standard Supportive Care

Sponsor

Dr. Lutfi Kirdar Kartal Training and Research Hospital